Novo Nordisk launches anti-diabetes pill semaglutide in India - Economic Times

8:32am PST - January 20th, 2022    health - The Times of India

Novo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.